Newest work from our group led by Amy Schade shows that EZH2 and AKT inhibitors combine to induce shrinkage of TNBC tumors by hijacking mechanisms of involution, now published in @Nature nature.com/articles/s4158…
www.nature.com AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution Nature - AKT inhibitors synergize with agents that suppress the histone methyltransferase EZH2 and promote robust tumour regression in multiple triple-negative breast cancer models in vivo by...